TELA Bio Inc Forecast, price target & analysts
TELA Bio Inc Target price 2026 - Analyst rating & recommendation
TELA Bio Inc Classifications & Recommendation
TELA Bio Inc Price Target
| Target Price | $2.04 |
| Price | $1.26 |
| Potential |
61.90%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target TELA Bio Inc 2027 .
The average TELA Bio Inc target price is $2.04.
This is
61.90%
register free of charge
$3.15
150.00%
register free of charge
$1.01
19.84%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend TELA Bio Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the TELA Bio Inc stock has an average upside potential 2027 of
61.90%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 80.28 | 81.25 |
| 15.84% | 1.20% | |
| EBITDA Margin | -40.79% | -36.66% |
| 30.50% | 10.14% | |
| Net Margin | -48.37% | -38.37% |
| 11.42% | 20.67% |
7 Analysts have issued a sales forecast TELA Bio Inc 2026 . The average TELA Bio Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an TELA Bio Inc EBITDA forecast 2026. The average TELA Bio Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 TELA Bio Inc Analysts have issued a net profit forecast 2026. The average TELA Bio Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.83 | -0.70 |
| 37.59% | 15.66% | |
| P/E | negative | |
| EV/Sales | 1.02 |
7 Analysts have issued a TELA Bio Inc forecast for earnings per share. The average TELA Bio Inc EPS is
This results in the following potential growth metrics and future valuations:
Current TELA Bio Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citizens |
Locked
➜
Locked
|
Locked | Mar 27 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 25 2026 |
| Lake Street |
Locked
➜
Locked
|
Locked | Mar 25 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Mar 25 2026 |
| Lake Street |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 18 2025 |
| Citizens |
Locked
➜
Locked
|
Locked | Nov 14 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Citizens:
Locked
➜
Locked
|
Mar 27 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 25 2026 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Mar 25 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Mar 25 2026 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 18 2025 |
|
Locked
Citizens:
Locked
➜
Locked
|
Nov 14 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
